MCM2 knockdown significantly reduced cell proliferation in ovarian cancer cells and reported a higher expression of p53 and γ-H2A histone family member X in carboplatin-treated cells, suggesting a role of MCM2 in carboplatin resistance [49]. This evidence concerns the gene TP53 and ovarian carcinoma.